TinyTax TinyTax 16087976 Board of Directors Audit Exempt Micro-Entity Accounts 19 November 2024 30 November 2025 30 November 2025 No description of principal activity false 28 July 2026 2 iso4217:GBP xbrli:pure 16087976 2023-11-19 2024-11-30 16087976 2025-11-30 16087976 2024-11-19 2025-11-30 16087976 2024-11-30 16087976 countries:EnglandWales 2024-11-19 2025-11-30 16087976 uk-bus:Micro-entities 2024-11-19 2025-11-30 16087976 uk-bus:AuditExempt-NoAccountantsReport 2024-11-19 2025-11-30 16087976 uk-bus:FilletedAccounts 2024-11-19 2025-11-30 16087976 uk-bus:Director1 2024-11-19 2025-11-30 16087976 core:WithinOneYear 2025-11-30 16087976 core:WithinOneYear 2024-11-30 16087976 core:AfterOneYear 2025-11-30 16087976 core:AfterOneYear 2024-11-30 16087976 uk-bus:CompanyLimitedByGuarantee 2024-11-19 2025-11-30 16087976 curr:PoundSterling 2024-11-19 2025-11-30

# MEDICAL AND SURGICAL ARTIFICIAL INTELLIGENCE RESEARCH COLLABORATIVE LTD

Company Registration Number
16087976
(England and Wales)

Private company limited by guarantee
Registered office: Flat 169 Residence Tower Woodberry Grove, London, N4 2BS, England

## Audit Exempt Micro-Entity Accounts

For the Period from 19 November 2024 to 30 November 2025

Prepared in accordance with the micro-entity provisions
of the Companies Act 2006 and FRS 105

1

# MEDICAL AND SURGICAL ARTIFICIAL INTELLIGENCE RESEARCH COLLABORATIVE LTD

## Contents

Balance Sheet | 3
Statement of Compliance | 4
Notes to the Financial Statements | 5-7

2

# MEDICAL AND SURGICAL ARTIFICIAL INTELLIGENCE RESEARCH COLLABORATIVE LTD

## Balance sheet

As at 30 November 2025

| 2025 £
Current assets | 0
Creditors: amounts falling due within one year | 0
Net current assets (liabilities) | 0
Total assets less current liabilities | 0
Total net assets (liabilities) | 0
Capital and reserves | 0

3

# MEDICAL AND SURGICAL ARTIFICIAL INTELLIGENCE RESEARCH COLLABORATIVE LTD

## Balance sheet continued

For the period ending 30 November 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

The accounts were approved by the Board of Directors and authorised for issue on 28 July 2026.

ZHAO, Yi, Dr
Director

4

# MEDICAL AND SURGICAL ARTIFICIAL INTELLIGENCE RESEARCH COLLABORATIVE LTD

## Notes to the Financial Statements

for the Period from 19 November 2024 to 30 November 2025

### 1. Accounting Policies

Turnover
Turnover is recognised when goods are delivered or services are provided.

Taxation
Corporation tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Debtors
Debtors are recognised at the settlement amount due.

Cash at bank and in hand
Cash at bank and in hand includes cash and short term highly liquid investments.

Creditors
Creditors are recognised when there is an obligation at the balance sheet date as a result of a past event.

5

# MEDICAL AND SURGICAL ARTIFICIAL INTELLIGENCE RESEARCH COLLABORATIVE LTD

## Notes to the Financial Statements (continued)

### 2. Basis of Preparation

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

This is the company's first period of trading. No comparative figures are presented.

6

# MEDICAL AND SURGICAL ARTIFICIAL INTELLIGENCE RESEARCH COLLABORATIVE LTD

## Notes to the Financial Statements (continued)

### 3. Employee Information

The average number of employees during the year was: 2

7